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Abstract Tbx3, a T-box transcription factor, regulates
key steps in development of the heart and other organ
systems. Here, we identify Sox4 as an interacting partner of
Tbx3. Pull-down and nuclear retention assays verify this
interaction and in situ hybridization reveals Tbx3 and Sox4
to co-localize extensively in the embryo including the
atrioventricular and outﬂow tract cushion mesenchyme and
a small area of interventricular myocardium. Tbx3, SOX4,
and SOX2 ChIP data, identify a region in intron 1 of Gja1
bound by all tree proteins and subsequent ChIP experi-
ments verify that this sequence is bound, in vivo, in the
developing heart. In a luciferase reporter assay, this ele-
ment displays a synergistic antagonistic response to co-
transfection of Tbx3 and Sox4 and in vivo, in zebraﬁsh,
drives expression of a reporter in the heart, conﬁrming its
function as a cardiac enhancer. Mechanistically, we pos-
tulate that Sox4 is a mediator of Tbx3 transcriptional
activity.
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Introduction
The T-box genes encode a phylogenetically conserved
family of transcription factors that share a common
DNA-binding motif known as the T-box domain. They
play crucial roles in development where they are impli-
cated in patterning, early cell-fate decisions, and many
aspects of organogenesis [1]. Mutations of T-box genes
have been associated with human disorders such as
DiGeorge, Holt-Oram, and ulnar-mammary syndromes
[2, 3].
Tbx2 and Tbx3 are closely related homologues of the
T-box family that are expressed in many overlapping
areas during development, including the heart, limbs, and
lungs [1]. They typically function as transcriptional
repressors and have been shown to have many, if not all,
target genes in common, including regulators of the cell
cycle [1]. In addition to their roles during development,
Tbx2 and Tbx3 are also found over-expressed in mela-
noma, breast, and pancreatic cancers [4–6]. Their role in
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123cancer may be related to their capacity to bypass senes-
cence by repressing expression of p14ARF and P21CIP1
[7–9].
During heart development, Tbx3 is required for
development of the cardiac conduction system and out-
ﬂow tract [10–13]. In the myocardium of the sinus node
and the atrioventricular bundle, Tbx3 represses a chamber
myocardium-speciﬁc gene program, including the gap
junction genes Gja1 and Gja5, encoding connexin 43
(Cx43) and Cx40 respectively, and natriuretic peptide
precursor type A (Nppa). The hypothesis has thus been
put forward that Tbx3 functions by imposing a primitive
‘nodal’ like phenotype on this early myocardium [10, 14–
16]. Furthermore, Tbx3 null mice display defects in out-
ﬂow tract development that have implied a role of Tbx3
in cardiac neural crest development and signaling between
neural crest and the second heart ﬁeld [11, 12]. Although
these results have provided valuable insights into the roles
of Tbx3 during multiple aspects of heart development,
many of the underlying molecular mechanisms remain to
be elucidated.
There are basically two aspects that dictate transcrip-
tion factor binding to promoters and regulatory gene
elements; the DNA sequence that is recognized and bound
by the transcription factor and its repertoire of speciﬁc
protein–protein interactions that can be made with other
regulatory proteins. Both of these elements will deﬁne the
ultimate transcriptional function of the factor and hence
its downstream gene targets. The T-box factors Tbx2,
Tbx3 and Tbx5 are known, for instance, to bind the
homeobox protein Nkx2.5 [13, 17–19]. Since T-box fac-
tors are expressed and are required for the development of
many different organs and tissues, complex forming with
a factor such as Nkx2.5, which has a more cardiac-
restricted expression pattern, may be instrumental in
determining a set of heart speciﬁc T-box target genes.
With the recent advent of ChIP-seq [20] a physical map
of a transcription factor’s genome-wide DNA-binding
proﬁle can be generated. Combining datasets generated
from different transcription factors, especially those
known to interact, to search for small overlapping regions
of binding, can be a powerful technique in deﬁning reg-
ulatory elements, such as enhancers, and co-regulated
genes.
While insights into the protein–protein interactions of a
transcription factor provides useful molecular information,
deﬁning the function of the interaction in vivo, particu-
larly in higher eukaryotes, can be a long and challenging
path. Here, we describe a novel protein–protein interac-
tion between Tbx3 and Sox4. Expression analysis shows
multiple sites of coexpression in- and outside the
embryonic heart at which this interaction may be func-
tional. Their interaction was subsequently veriﬁed using
both in vitro and sub-cellular localization assays. To
explore the functional relevance of this novel interaction,
heart-speciﬁc Tbx3 ChIP-seq data was compared to ChIP-
seq and ChIP-chip data available for SOX2 and SOX4,
which lead to the identiﬁcation of a 1-kb regulatory ele-
ment in intron 1 of Gja1 that is bound by both Tbx3,
Sox4, and P300 in the developing mouse heart. In vitro,
this element could activate a basal promoter and could be
used to demonstrate a synergistic interaction between
Sox4 and Tbx3. Its speciﬁc functionality as a cardiac
enhancer could also be demonstrated, in vivo, using a
zebraﬁsh model system.
Materials and methods
Plasmid constructs
Full-length (aa 1–723/743) and T-box region (aa 94–300/
320) of Tbx3 or Tbx3 isoform2 (?exon 2a) were PCR
ampliﬁed from human cDNA (NM_005996/NM_016569)
and cloned into pMAL2C (Clontech) to generate MBP
fusion constructs. Full-length (aa 1–440) and N-terminal
fragments (aa1–153, aa1–136, aa1–125) of SOX4 were
PCR ampliﬁed from mouse cDNA (NM_009238) and
cloned into pRP256nb to generate GST fusion constructs,
or into pcDNA-myc (full length only) to generate myc-
SOX4. Constructs encoding MBP-Tbx2-T-box, MBP-
Tbx5-T-box, GST-Nkx2.5, HA-Tbx3, myc-Nkx2.5 have
been described before [10, 21].
Yeast 2-hybrid screen
The T-box region of mouse Tbx3?2a (aa 94–320,
NM_198052) was cloned into pGBKT7 (Clontech) and
tested for self-activation by co-transfection to yeast strain
AH109 (Clontech) with empty activation domain (AD)
plasmid pGADT7 (Clontech). Bait construct was trans-
formed into AH109, which was subsequently mated with
yeast strain Y187 that was pretransformed with prey library
of mouse embryonic day (E) 11.5 cDNA (Clontech)
according to the manufacturer’s instructions. Clones were
selected on triple-drop-out selection media lacking leucine,
tryptophan and histidine in the presence of the galactoside
X-a-Gal. Surviving colonies were replated to triple drop
out medium and subsequently picked for AD-plasmid
rescue and sequencing.
In vitro protein interactions assay
MBP pulldown assays were performed as described before
[21], using anti-GST (GST-2, Sigma-Aldrich) as primary
antibody for Western detection.
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Cells were transfected with 375 ng DNA of each plasmid,
empty vector was added such that all cells received the
same amount of total DNA. Primary antibodies used were
rabbit anti-HA (H6908, Sigma-Aldrich), mouse anti-myc
(9E10, Santa-Cruz) at 1:250 dilutions, and secondary
antibodies were Alexa Fluor 488 goat anti-rabbit IgG and
Alexa Fluor 568 goat anti-mouse IgG (Molecular Probes),
at 1:250 dilutions. TO-PRO3 (Invitrogen) was used for
nuclear counterstaining. Immunoﬂuorescent detection of
proteins was repeated at least three times, and representa-
tive examples were photographed on a Leica DM5500
confocal laser microscope (Leica).
In situ hybridization
In situ hybridization was performed as described before on
10-lm-thick sections [22]. T-box antisense probes have
been described previously [23]. Sox4 probe was generated
using a template based on the 30UTR of Sox4 (1,885–2,886
of mouse Sox4 mRNA (NM_009238)).
ChIP data-analysis
Conditional Tbx3 over-expressing and cardiac speciﬁc
tamoxifen inducible Cre (Mer-Cre-Mer) mice have been
described before [10, 24]. Male mouse hearts were isolated
4 days after intra-peritoneal injections of tamoxifen, and
Tbx3 over-expression was conﬁrmed by qRT-PCR, in situ
hybridization and immunohistochemistry (not shown).
ChIP was performed on mouse hearts using anti-Tbx3
(A-20, Santa-Cruz). In this case Mer-Cre-Mer mice, lack-
ing the Tbx3 expression construct, injected with tamoxifen
served as ChIP control. Isolated DNA fragments were
analyzed using high-throughput sequencing (data and
analysis will be published elsewhere). Data signiﬁcance of
Tbx3-binding peaks were analyzed using a Fisher’s exact
test with comparison to ChIP control data. SOX4 and
SOX2 ChIP data were obtained from NCBI gene expres-
sion omnibus (accession: GSE11874; [25, 26]) and
analyses on data were carried using the Web-based soft-
ware Galaxy (http://galaxy.psu.edu/). Annotated genes co-
occurring in both assays were selected for further analysis.
Transcription factor binding site prediction
To identify potential Sox4 and Tbx3-binding sites, high-
quality position weight matrices from the Jaspar database
were used (http://jaspar.genereg.net/; MA0009.1 for T-box-
binding sites; MA0077.1, MA0078.1, MA0084.1,
MA0087.1, MA0143.1 and MA0442.1 for Sox HMG-box-
binding sites). In addition, the predicted wwCAAwG
sequence for Sox4 binding was searched [27]. Relative
score threshold was set to 85% (Sox) or 70% (Tbx).
In vivo ChIP
For Tbx3 and SOX4 ChIP experiments, 36 hearts of
ED10.5 wild-type mouse embryos were isolated and ﬁxed
at room temperature for 15 min with 1% formaldehyde.
Cells were lysed and Dounce homogenized. Cross-linked
nuclei were sonicated to obtain chromatin fragments with
average size of *400 bp. Pre-cleared chromatin fragments
were incubated at 4C for 4 h with 10 lg antibodies
against Tbx3 (A-20, sc-17871, Santa Cruz Biotechnology)
or SOX4 (C-20, sc-17326, Santa Cruz Biotechnology).
Protein G beads were added to capture the chromatin-
antibody complex. After ﬁve washing steps, the protein-
DNA complex was eluted with 100 mM NaHCO3 and 1%
SDS at room temperature, and cross-linking was reversed
by incubating at 65C overnight. After RNaseA and Pro-
teinase K treatments, the DNA fragments were puriﬁed by
phenol–chloroform, precipitated in ethanol and dissolved
in 50 llH 2O, and analyzed using PCR. PCR primers are
listed in Table 1. p300 ChIP was performed in wild-type
adult mouse heart using an antibody against p300 (C-20,
sc-585, Santa Cruz Biotechnology) as described above,
with the modiﬁcation of cross-linking for 1 h with 2%
formaldehyde. In all cases, control PCRs represent regions
found not to bind Tbx3 in ChIP-seq dataset or SOX4 based
on the published SOX4 ChIP data.
ChIP QPCR reactions were performed and analyzed as
described previously [21]. In vivo ChIP reactions were
performed as described above, using 40 embryonic (ED
10.5) mouse hearts and matched IgG antibody (Santa Cruz,
sc-2028) as a negative control.
Zebraﬁsh enhancer assay
The putative Gja1 enhancer sequence was cloned into
pGEM-T Easy (Promega) and ampliﬁed by PCR. The
resulting PCR product was then cloned in a plasmid con-
taining the e1b minimal ﬁsh promoter driving the
expression of a H2A-eGFP fusion protein, upstream of the
e1b sequence, generating pTOL2-EnhGja1-H2AeGFP.
pTOL2-EnhGja1-H2AeGFP was injected in zebraﬁsh
embryos at 1-cell stage at a ﬁnal concentration of 10 ng/ll
in presence of 25 ng/ll TOL2 transposase RNA. Embryos
were subsequently kept at 28.5C in E3 medium and
imaged at 72 hpf.
Luciferase assays
COS7 cells, grown in 12-well plates in DMEM supple-
mented with 10% FCS (Gibco-BRL) and glutamine, were
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123transfected using polyethylenimine 25 kDa (PEI) (Bruns-
chwick) at a 1:3 ratio (DNA:PEI). Reporter construct was
generated by ligating Cx43 putative enhancer region
(chr10:56,097,392–56,098,369) to pGL2basic?minimal
promoter (control reporter). Standard transfections used
1.6 lg of reporter (or control reporter) vector cotransfected
with 3 ng phRG-TK Renilla vector (Promega) as normal-
ization control. pCDNA3 constructs expressing Tbx2,
Tbx3, Tbx5, and SOX4 were cotransfected as appropriate.
Transfections were carried out at least four times and
measured in duplo. Luciferase measurements were per-
formed using a Promega Turner Biosystems Modulus
Multimode Reader luminometer. All data was statistically
validated using an ANOVA two-way test for all combi-
nations of Sox4 and T-box.
Results
Tbx3 interacts with Sox4
To gain further insight into the molecular mechanisms by
which Tbx3 controls gene expression, we performed a
yeast 2-hybrid screen with Tbx3 as bait. From an initial
screen of[1 9 10
6 colonies, 12 surviving clones revealed
a GAL4 fusion to a peptide ([40 aa) in a reading frame
coding for a BLASTP genome identiﬁable sequence. Two
of these clones encoded an N-terminal fragment of Sox4, a
high mobility group (HMG) domain containing transcrip-
tion factor that has been previously shown to be essential
for normal outﬂow tract development and atrioventricular
valve formation [28–30]. The fragment encodes amino
acids 3–153 of mouse Sox4, which contains the entire
HMG domain. No other functional domains have been
identiﬁed within this part of the protein and a database
search for conserved domains using the NCBI CDD search
option revealed no other conserved domains in this frag-
ment (Fig. 1a; [31–33]).
Tbx3 and Sox4 interact via their DNA-binding domains
To validate and further investigate the interaction between
Tbx3 and Sox4, we performed in vitro binding assays using
bacterially expressed Tbx3 fused to MBP and Sox4 fused
to GST. Both full-length Sox4 and the N-terminal fragment
that was identiﬁed in the screen, are able to interact with
MBP-Tbx3, but not with MBP alone (Fig. 1b). We next
tested whether binding of Tbx3 to Sox4 is unique among
T-box proteins, or whether the cardiac expressed T-box
proteins Tbx2 and Tbx5 can also bind to Sox4. We found
that the T-box of Tbx2 and Tbx5 are able to bind the
N-terminal Sox4 fragment as well (Fig. 1b), suggesting a
level of binding promiscuity between Sox4 and T-box
proteins. Further, the apparently redundant isoform of Tbx3
(Tbx3?2a) [34], which differs from Tbx3 by a single 20
amino acid insertion within the T-box domain, shows
similar binding properties (Fig. 1b).
Multiple bands were observed in the binding between
full-length Sox4 and Tbx3 (Fig. 1b), which likely represent
carboxy-terminal speciﬁc protein degradation by Esche-
richia coli endoproteases or premature GST-fused
termination products. Strikingly, the size of the smallest of
these products that still interacts with Tbx3 equals the size
of the N-terminal fragment that was picked up in the two-
hybrid screen. Smaller protein fragments, therefore, do not
interact with Tbx3, indicating that further shortening of
Sox4 would disrupt the interaction domain. To test this
hypothesis, we compared binding of three N-terminal
fragments (Fig. 1c). Stepwise truncation of Sox4 showed
that the shortest construct, 136 residues in length that still
binds Tbx3 contains the full HMG domain. Shortening this
construct further to 125 residues results in a complete loss
of interaction.
In summary, our in vitro binding assays show a strong
interaction between Tbx3 and Sox4, which is mediated by
their conserved DNA-binding regions; the T-box and the
HMG-domain.
Table 1 Experimental PCR primer pairs
Genomic region Associated gene Primer pairs (50–30)
chr10:56097622–56097940 Gja1 TCGCCAATGGAGAAGGTGTTGC
GCATCGCACAGGCTTGCACA
chr10:56097812–56097961
a Gja1 GCAGCAGTTGACTTCCACGTGGT
GGCTAAGAGGTTCATCCCGTAGCA
chr4:147374511–147374593
a Nppa CTGTTGCCAGGGAGAAAGAATC
TTCAAAGGTGTGAGAGGAGCAG
chr1:95600109–95600443 Intergenic CCCAGAGCTTCCCGGTGCTT
Negative control CAGGGAGGCTCCACCCGTTG
a Primer pairs used for QPCR
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context
To address whether the interaction between Tbx3 and Sox4
can also occur in mammalian cells, we analyzed the sub-
cellular distribution of HA-tagged Tbx3 by immunoﬂuo-
rescence in HEK293 cells. When transfected to HEK cells,
both Tbx3 isoforms are localized primarily in the cyto-
plasm, although some nuclear localization can be detected
(Fig. 2) (Tbx3?2a data not shown). This behavior is
unique for this cell line and is not observed in other cell
lines such as COS7 or the cardiac H10 cell line (not shown)
were Tbx3 is found almost exclusively in the nucleus. The
cardiac transcription factor Nkx2.5, a known interaction
partner of Tbx3, and Sox4 both localize to the nucleus
when singularly transfected to HEK cells (Fig. 2). Upon
co-transfection of Tbx3 with either Nkx2.5 or Sox4, Tbx3
could be detected nearly exclusively in the nucleus of HEK
cells (Fig. 2), showing that both Nkx2.5 and Sox4 can
interact with Tbx3 and facilitate its retention within the
nucleus. The absence of nuclear retention of Tbx3 upon
co-transfection of non-interacting nuclear localized GFP
conﬁrmed that the interaction was speciﬁc for Sox4 and
Nkx2.5.
Tbx3 and Sox4 are co-expressed during heart
development
The observation that Tbx3 and Sox4 interact in vitro and in
mammalian cells raises the question whether these proteins
also interact during development. To determine in which
tissues such a molecular interaction may occur, we com-
pared the expression patterns of Sox4 and Tbx3 and the
closely related Tbx2 and Tbx5 genes using in situ hybrid-
ization analysis of E11.5 mouse embryos. Sox4 is
coexpressed with Tbx2, Tbx3 and Tbx5 in the thoracic body
wall, mandibular component of the ﬁrst branchial arch, the
developing lungs, and the midgut (Fig. 3)[ 19, 23]. In the
heart, Sox4 expression in the endocardium and mesen-
chyme of the cardiac cushions overlaps with Tbx2 and
Tbx3. We also detect Sox4 expression in the ventral aspect
of the interventricular ring, a subpopulation of primitive
Fig. 1 The T-box of Tbx3 interacts with the HMG domain of SOX4.
a Diagram showing full-length SOX4 with conserved domains, and
the clone that was identiﬁed in our screen (SOX4-N). The sequence of
a fragment containing the 3rd a-helix (underlined) of the HMG box
(bold) and its C-terminal tail (italics) is shown, with the positions of
truncated constructs (125, 136). b MBP pulldown assays showing that
GST tagged Nkx2.5, SOX4 and SOX4-N bind to MBP-Tbx3 (middle
panel) but not MBP alone (left). The T-box domain only of Tbx3 and
that of Tbx2, Tbx3?2a and Tbx5 retain the ability to bind to the
HMG domain of SOX4 (right). c Mapping of the interaction domain
of SOX4 showing that the construct that misses the C-terminal tail
(SOX4-125) does not interact with the T-box, whereas longer
constructs do. CD Central domain, S serine-rich region, TA transac-
tivation domain
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tract (Figs. 3, 4); [35].
A potential downstream target of the Tbx3–Sox4
interaction
For many transcription factors, including T-box proteins,
target promoter speciﬁcity may be achieved through
interaction with other proteins [17, 18, 36, 37]. In several
recent studies, we and others have addressed the functional
role of T-box proteins, particularly Tbx3, in the develop-
ment of AV and outﬂow regions of the heart [11, 12, 38,
39]. Complimentary to recent microarray experiments to
determine the downstream targets of Tbx3 [10] (unpub-
lished data, MLB, VMC), we have carried out a Tbx3
ChIP-seq experiment to identify direct gene targets and
provide a genome-wide map of Tbx3-binding sites (com-
plete dataset will be published elsewhere). The quality of
the data generated by this ChIP-seq approach could be
validated by the marked presence in the sequence peaks of
several published T-box-binding sites and gene enhancer
elements (Supplementary Fig. 1). Spurred by our novel
ﬁnding of expression of Sox4 in the myocardium, we were
intrigued by recent reports describing ChIP-binding
experiments of SOX2 and SOX4 [25, 26]. Close exami-
nation of these datasets revealed an evolutionarily
conserved region in the ﬁrst intron of the Gja1 gene, that is
bound by both SOX2 and SOX4. Repression of Gja1 in the
heart is known to involve Tbx2 and Tbx3, which may
display redundant roles in this process. Furthermore,
myocardial Gja1 expression is complimentary to myocar-
dial expression patterns of Tbx2 and Tbx3 [12, 19, 21], as
well as the myocardial expression of Sox4 (Fig. 4). As
shown in Fig. 5a, our Chip-seq data shows that the same
region of Gja1 in intron 1 as found in the SOX2 and SOX4
ChIP experiments is also bound by Tbx3, implicating that
it may be a conserved genomic element important for the
regulation of Gja1. A transcription factor-binding site
Fig. 2 Tbx3 and SOX4 interact
in HEK293 cells. Cells were
transfected with expression
constructs for HA-tagged Tbx3
in the presence or absence of
nls-eYFP, SOX4, or Nkx2.5
(myc-tagged). Cytoplasmic
Tbx3 is efﬁciently relocalized to
the nucleus upon co-expression
of SOX4 and Nkx2.5, whereas
co-expression of the unrelated
eYFP protein does not inﬂuence
subcellular localization of Tbx3
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(Jaspar database) yielded as many as 11 potential Sox-
binding sites and 4 potential T-box-binding sites (Fig. 5a).
A small element in intron 1 of Gja1 is occupied
by Tbx3, Sox4, and P300 in vivo and drives expression
in the vertebrate heart
Sox protein ChIP studies and our own mouse heart Tbx3
ChIP studies made use of different organisms and tissue
types. Both Sox studies were carried out in human tissues,
SOX2 making use of a ChIP-microarray approach in
embryonic stem cells and SOX4, a ChIP-chip in a prostate
cell line. We therefore ﬁrst validated that both Tbx3 and
Sox4 could occupy this element in the same system. To this
end, a ChIP analysis was carried out using embryonic day
11.5 hearts isolated from wild-type mice. Using either anti-
Tbx3 antibodies, anti-Sox4 antibodies, or matched IgG as
control, both Tbx3 and Sox4 are found to occupy this
region of Gja1, in vivo, at the same stage of mouse heart
development (Fig. 5b). Since the region identiﬁed in Gja1
may represent an as yet unidentiﬁed enhancer element, we
decided to test for P300 association. P300 is a ubiquitously
expressed protein known to bind active enhancers across
the genome [40]. Using ChIP–PCR (Fig. 5c), P300 can
indeed be found to bind this region in vivo, an observation
that is in agreement with P300 embryonic heart ChIP-seq
data recently generated by Blow and coworkers [41]
(Fig. 5a). To further validate that the Gja1 intronic element
can function as an enhancer in vivo, we tested the
expression of GFP under control of this element, using a
zebraﬁsh enhancer assay system. GFP expression in zeb-
raﬁsh can be found restricted to the heart and shows a
conﬁnement to cells of the ventricle and, albeit a lower
level, the atrium (Fig. 5d). No expression was observed in
control ﬁsh carrying the construct lacking the enhancer
Fig. 3 Sagittal sections of
E11.5 mouse embryos showing
colocalization of Sox4 with
T-box factors at multiple sites.
a Consecutive sections of
mouse embryo showing
colocalization of Sox4 with
Tbx2 and Tbx3 in mandibular
component of the ﬁrst branchial
arch, and the midgut and with
Tbx2, Tbx3 and Tbx5 in the
developing heart, lungs and
body wall. cTnI marks all
myocardium. b Expression of
Sox4 in the heart is localized in
the endocardium and
mesenchyme of the
atrioventricular (*) outﬂow tract
cushions (
#), sites of abundant
Tbx2 and Tbx3 expression.
Tbx2 and Tbx3 are also
expressed in the atrioventricular
myocardium underlying the
cushions, a region that does not
express Sox4. Dotted lines mark
contours of the myocardium.
m Mandibular component, li
liver, lu lung, th thyroid, mg
midgut, bw body wall, a atrial
lumen, v ventricular lumen,
oft(m) outﬂow tract
(myocardium), ift inﬂow tract,
end endocardium, mes cushion
mesenchyme, avc(m)
atrioventricular canal
(myocardium), sv sinus vinosus,
cr cranial, ca caudal, ve ventral,
do dorsal
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displayed pericardial edema, indicating a level of enhan-
cer-construct toxicity.
Assessing the synergistic potential of the Tbx3–Sox4
interaction using the Gja1 enhancer element
To test the function of this enhancer element in-terms of
the Tbx3–Sox4 complex, it was cloned upstream of a
minimal E1b promoter sequence and tested for its ability to
induce expression of a luciferase reporter gene in COS7
cells (Fig. 6). Signiﬁcant up-regulation, 15-fold, of lucif-
erase was observed using this construct when compared to
the empty vector possessing the minimal promoter alone.
Both Tbx2 and Tbx3 were able to signiﬁcantly down-reg-
ulate expression of luciferase from this construct. Tbx5 has
no signiﬁcant effect when co-transfected. Addition of Sox4
alone resulted in an eightfold increase in luciferase
expression. However, in the presence of Sox4, Tbx2, and
Tbx3 displayed a signiﬁcantly increased capacity to down-
regulate this enhancer element. In this context, addition of
Tbx5 had no signiﬁcant effect on luciferase expression.
These results indicate a competitive and yet synergistic
transcription effect of Sox4 on both Tbx2 and Tbx3.
Discussion
Members of the T-box and Sox families of transcriptional
regulators control a diverse array of processes during
vertebrate embryonic development [13, 42]. In this study,
we present evidence that Tbx3 and Sox4 interact via their
DNA-binding domains, both in vitro and in mammalian
cells. Comparative expression and ChIP analysis also
demonstrates that this interaction may be functional at
transcriptional regulation sites during development and that
Sox4 may facilitate the transcriptional activities of Tbx3 at
gene enhancer locations.
The interaction studies presented here show that the
DNA-binding domains of Tbx3 and Sox4 interact. Since
this interaction occurs through highly conserved domains,
one might expect other members of the T-box family to be
able to interact with Sox4. Indeed, the related proteins
Tbx2 and Tbx5 also bind Sox4. The apparent lack of
speciﬁcity within this closely related group of T-box fac-
tors is also evident for Nkx2.5 and Gata4, which partner-up
with multiple T-box genes (reviewed in [43]). The func-
tionality of these interactions is likely dictated by the
timing and (co-) localization of expression and the relative
expression levels of the different T-box factors.
In relation to the speciﬁc molecular function and sig-
niﬁcance of the T-box–Sox interaction we describe here,
Sox proteins appear to predominantly function as tran-
scriptional activators [44, 45], often serving to position
gene enhancers, by DNA bending and opening [46], in a
more fortuitous position for functional interaction of other
transactivating factors. In this respect, addition of Sox4 in
our transfection assays agrees with this statement, though
at the same time the activities of Tbx3 and Tbx2, serving to
down regulate transactivation, also appears to be facilitated
Fig. 4 Sox4 is expressed in the ventral aspect of the interventricular
ring. In situ hybridization of E11.5 mouse heart showing cTnI stained
myocardium, Cx43 and Sox4 expression. The bottom panel focusing
on the myocardial expression zone of Sox4 at the border of the left
ventricle and outﬂow tract. la Left atrium, ra right atrium, lv left
ventricle, rv right ventricle, oft outﬂow tract, cus cushion mesen-
chyme, myo myocardium
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123by the presence of Sox4. It is interesting that Sox proteins
are known to interact with a wide range of transcription
factors [47] and as such may function here in facilitation of
a transcriptional response based on the factor(s) present.
Therefore the total transcriptional response of a gene or set
of genes is not being driven by an individual protein, but by
Fig. 5 Regulation by T-box proteins and SOX4 of a putative Gja1
enhancer. Overlapping SOX2 ChIP-seq, SOX4 ChIP-chip, P300
ChIP-seq, and Tbx3 ChIP-seq data in intron 1 Gja1. a Visualized as
UCSC custom tracks. Tbx3 data shows peak proﬁles for tags
sequenced in hearts from Tbx3-induced mice. Predicted binding sites
for T-box factors (open triangles) and Sox proteins (closed triangles)
are indicated. b In vivo veriﬁcation of Tbx3 and Sox4 association
within this overlap (black line with arrow heads (Fig. 5a) marks the
position of the target ampliﬁcation, Gja1) using ChIP-QPCR. The
result is presented as an enrichment relative to an IgG control.
Ampliﬁcation of the known T-box-binding site [36] within the
proximal Nppa promoter is also shown. This region (supplementary
Fig. 1) shows the expected enrichment for Tbx3, but no enrichment
for Sox4, as based on the Tbx3 ChIP-seq and the SOX4 ChIP-chip
data. c In vivo veriﬁcation using ChIP-PCR of Tbx3, Sox4 and p300
association within this overlapping binding region. In this case, the
negative controls are carried out using the same ChIP chromatin from
the Tbx3, Sox4, and P300 IPs in combination with primers speciﬁc to
a genomic region known not to bind Tbx3, Sox4, or P300. d In vivo
analysis of zebraﬁsh embryos (72 hpf) expressing H2AeGFP fusion
protein under control of the minimal e1b promoter (Control) and
minimal promoter ? putative Gja1 enhancer (Enhancer). The geno-
mic region used to generate this clone is marked with a solid green
bar in Fig. 5a. Fish with this Gja1 enhancer construct clearly show
restricted and speciﬁc expression of eGFP in the ventricle and atrium
of the heart. V Ventricle, A atrium, P pericardium
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123the stoichiometry and make-up of the complex of which it
is a member.
We show that the C-terminal part of the HMG domain is
essential for the interaction between Tbx3 and Sox4. Pro-
tein–protein interactions of Sox2, Sox8 and Sox10 with
other transcription factors were also shown to be mediated
by the C-terminal part of the HMG domain, which includes
helix 3 and the C-terminal tail region [47–49]). These
regions are not involved directly in establishing DNA
contacts and are still available for interactions with other
proteins even when Sox proteins are DNA bound [48, 50].
Similarly, the high degree of sequence conservation
between HMG domains suggests that other members of the
Sox family may also interact with Tbx3 [49]. For instance,
the very early expression of Tbx3 in the inner cell mass of
the blastocyst, where related T-box factors are not yet
expressed, coincides with Sox2 expression, thus repre-
senting an example of a potentially interesting interaction
worth further investigation [23, 51]. This statement seems
particularly prudent in light of the recent publication sug-
gesting a role for Tbx3 alongside Sox2 in maintaining stem
cell pluripotency during embryonic stem cell development
[52].
The novel ﬁnding of Sox4 in a small localized region of
the interventricular ring myocardium, raises the question of
a speciﬁc function for Sox4 in the myocardium in this
region of the heart. Although Tbx3 and Tbx2 expression
overlap with Sox4 in this region of the myocardium and
may thus form a regulatory complex, by far the most
extensive co-expression in the heart is seen in the mesen-
chyme of the atrioventricular region and outﬂow tract. This
area is most likely the origin of the observed outﬂow tract
malformations and early death observed in Sox4 knock out
mice [28]. In this respect, and in terms of deﬁning a pos-
sible functional role for a T-box–Sox interaction, the
identiﬁcation of Gja1 as direct downstream target for both
Sox4 and Tbx3, is of particular relevance in terms of
outﬂow tract development [12, 28, 53, 54] and the devel-
opment of other tissues and organs such as the limbs [55,
56]. In humans, mutations in Gja1 give rise to the auto-
somal dominant disease oculodentodigital dysplasia
(ODDD) (OMIM #164200) affecting the face, eyes, teeth,
and limbs, and is associated with cardiac arrhythmia and
neurological disorders. In mice, a model for ODDD has
been generated by mutating Gja1. T h e s em i c ed i s p l a ya
phenotype overlap with the human disease, including
syndactyly and cardiac arrhythmias. Altered expression
of Cx43 has also been linked to numerous defects,
including cardiac conduction [57]a n dm o u s em o d e l s
have demonstrated that a critical regulation of Cx43 is
necessary for correct outﬂow tract development, with
over-expression and knockout models resulting in mal-
formations [54, 58, 59].
Tbx3 (and Tbx2) knockout studies show clear ectopic
expression of Cx43, revealing their key role in Gja1 reg-
ulation [10, 12, 38]. Interestingly, knockout studies of the
closely related T-box factor, Tbx5, have suggested that
Tbx5 plays no role in the regulation of Gja1 [36] and the
data we present here would seem to support this statement.
Previous studies relating to regulation of Gja1 by T-box
proteins have focused predominantly on upstream regions
shown to drive aspects of Cx43 expression [21, 60, 61].
However, to date, the elements that truly drive and control
cardiac Gja1 expression, in vivo, have not been identiﬁed.
Whereas the proximal promoter region does contain con-
served transcription factor binding sites that can be
functional in the repression or induction of reporter con-
structs in vitro, the 7-kb proximal promoter is not sufﬁcient
to drive expression in the heart [62]. Studies using this
proximal promoter region show that it does mark the neural
crest population which migrates to the outﬂow tract of the
heart where it populates the cushions and appears to play
some, as yet unknown, role in the septation of the outﬂow
tract and patterning of the aortic arch region [63].
Here we present evidence of a regulatory enhancer
positioned within intron 1 of Gja1, that we initially identify
on the basis of a localized binding afﬁnity for Tbx3, Sox2,
Sox4, and P300. This multi-factorial binding coupled with
Fig. 6 Transfection of luciferase under control of a minimal
promoter and the Gja1 enhancer. Transfections of a Gja1 intronic
enhancing region (marked with a solid green bar in Fig. 5a) reporter
construct in the presence of Tbx2, Tbx3 or Tbx5 and SOX4. Addition
of Tbx2 or Tbx3 alone results in an approximate 1.7-fold down-
regulation of enhancing activity. SOX4 alone is able to up-regulate
activity of this enhancer, but in the presence of Tbx2 and Tbx3
appears able to stimulate the down-regulation capacity of both Tbx2
and Tbx3. * and
# denotes p\0.0001
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123an in vivo expression study in zebraﬁsh provides strong
evidence that this region is a functional enhancer during
vertebrate heart development, which may be subject to
strict spatiotemporal regulation by various T-box com-
plexes including the T-box–Sox complex we describe here.
Further, this novel enhancer element that we identify in
intron 1 of Gja1 seems to contain sequences that induce
expression of Gja1 in the developing heart. It is also
interesting to note that the expression of GFP we observe in
zebraﬁsh, driven by this element, appears restricted to the
atrium and ventricle and is apparently absent from the
atrioventricular region. Recent studies tracing the expres-
sion of Tbx2 and Tbx3 isoforms in the zebraﬁsh heart have
shown a restriction of these factors to the atrioventricular
region of the heart after approximately 33 hpf [64, 65].
This seems to suggest that the element we identify shows a
level of functional as well as structural conservation. In
line with this hypothesis, we have initiated a study devoted
to investigating and dissecting the speciﬁc function of this
enhancer in the developing mouse heart to further address
these issues.
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